{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T23:32:52Z","timestamp":1771371172181,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Shanghai Municipal Health Bureau, Shanghai, China","award":["XBR2011069"],"award-info":[{"award-number":["XBR2011069"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81370678"],"award-info":[{"award-number":["81370678"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shanghai Municipal Council for Science and Technology","award":["12431902201"],"award-info":[{"award-number":["12431902201"]}]},{"name":"Shanghai Municipal Council for Science and Technology","award":["14411961500"],"award-info":[{"award-number":["14411961500"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12885-015-1973-7","type":"journal-article","created":{"date-parts":[[2015,12,16]],"date-time":"2015-12-16T21:12:07Z","timestamp":1450300327000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Epithelial ovarian cancer stem-like cells expressing \u03b1-gal epitopes increase the immunogenicity of tumor associated antigens"],"prefix":"10.1186","volume":"15","author":[{"given":"Xiaofen","family":"Yao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhangli","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuwan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongmei","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,16]]},"reference":[{"issue":"24","key":"1973_CR1","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMra041842","volume":"351","author":"SA Cannistra","year":"2004","unstructured":"Cannistra SA. Cancer of the ovary. N Eng J Med. 2004;351(24):2519\u201329.","journal-title":"N Eng J Med"},{"issue":"Suppl 1","key":"1973_CR2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1525-1438.2005.15351.x","volume":"15","author":"RF Ozols","year":"2005","unstructured":"Ozols RF. Treatment goals in ovarian cancer. Int J Gynecol Cancer. 2005;15 Suppl 1:3\u201311.","journal-title":"Int J Gynecol Cancer"},{"issue":"10","key":"1973_CR3","first-page":"675","volume":"8","author":"D Armstrong","year":"2010","unstructured":"Armstrong D. Update on treatment options for newly diagnosed ovarian cancer. Clin Adv Hematol Oncol. 2010;8(10):675\u20138.","journal-title":"Clin Adv Hematol Oncol"},{"issue":"1","key":"1973_CR4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/sj.cr.7310118","volume":"17","author":"F Li","year":"2007","unstructured":"Li F, Tiede B, Massague J, Kang Y. Beyond tumorigenesis: cancer stem cells in metastasis. Cell Res. 2007;17(1):3\u201314.","journal-title":"Cell Res"},{"issue":"3","key":"1973_CR5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s13277-011-0155-8","volume":"32","author":"S Soltanian","year":"2011","unstructured":"Soltanian S, Matin MM. Cancer stem cells and cancer therapy. Tumor Biol. 2011;32(3):425\u201340.","journal-title":"Tumor Biol"},{"issue":"8","key":"1973_CR6","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1158\/0008-5472.CAN-04-3931","volume":"65","author":"SA Bapat","year":"2005","unstructured":"Bapat SA, Mali AM, Koppikar CB, Kurrey NK. Stem and progenitor like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Res. 2005;65(8):3025\u20139.","journal-title":"Cancer Res"},{"issue":"11","key":"1973_CR7","doi-asserted-by":"crossref","first-page":"431l","DOI":"10.1158\/0008-5472.CAN-08-0364","volume":"68","author":"S Zhang","year":"2008","unstructured":"Zhang S, Balch C, Chan MW, Lai HC, Matei D, Schilder JM, et al. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res. 2008;68(11):431l\u201320.","journal-title":"Cancer Res"},{"key":"1973_CR8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1146\/annurev.immunol.021908.132544","volume":"27","author":"M Dougan","year":"2009","unstructured":"Dougan M, Dranoff G. Immune therapy for cancer. Annu Rev Immunol. 2009;27:83\u2013117.","journal-title":"Annu Rev Immunol"},{"issue":"5","key":"1973_CR9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3322\/caac.20132","volume":"62","author":"JM Kirkwood","year":"2012","unstructured":"Kirkwood JM, Butterfield LH, Tarhini AA, Zarour H, Kalinski P, Ferrone S. Immunotherapy of cancer in 2012. CA Cancer J Clin. 2012;62(5):309\u201335.","journal-title":"CA Cancer J Clin"},{"key":"1973_CR10","doi-asserted-by":"crossref","first-page":"h988","DOI":"10.1136\/bmj.h988","volume":"350","author":"LH Butterfield","year":"2015","unstructured":"Butterfield LH. Cancer vaccines. BMJ. 2015;350:h988.","journal-title":"BMJ"},{"issue":"10","key":"1973_CR11","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/nm1483","volume":"12","author":"L Jin","year":"2006","unstructured":"Jin L, Hope KJ, Zhai Q, Smadja-Joffe F, Dick JE. Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat Med. 2006;12(10):1167\u201374.","journal-title":"Nat Med"},{"issue":"13","key":"1973_CR12","doi-asserted-by":"crossref","first-page":"5259","DOI":"10.1158\/0008-5472.CAN-09-4313","volume":"70","author":"T Deguchi","year":"2010","unstructured":"Deguchi T, Tanemura M, Miyoshi E, Nagano H, Machida T, Ohmura Y, et al. Increased immunogenicity of tumor-associated antigen, mucin 1, engineered to express alpha-gal epitopes: a novel approach to immunotherapy in pancreatic cancer. Cancer Res. 2010;70(13):5259\u201369.","journal-title":"Cancer Res"},{"issue":"5","key":"1973_CR13","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1084\/jem.160.5.1519","volume":"160","author":"U Galili","year":"1984","unstructured":"Galili U, Rachmilewitz EA, Peleg A, Flechner I. A unique natural human IgG antibody with anti-alpha-galactosyl specificity. J Exp Med. 1984;160(5):1519\u201331.","journal-title":"J Exp Med"},{"issue":"7","key":"1973_CR14","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1128\/IAI.56.7.1730-1737.1988","volume":"56","author":"U Galili","year":"1988","unstructured":"Galili U, Mandrell RE, Hamadeh RM, Shohet SB, Griffiss JM. Interaction between human natural anti-alpha-galactosyl immunoglobulin G and bacteria of the human flora. Infect Immun. 1988;56(7):1730\u20137.","journal-title":"Infect Immun"},{"issue":"10","key":"1973_CR15","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.1016\/j.transproceed.2011.09.074","volume":"43","author":"A Mangold","year":"2011","unstructured":"Mangold A, Lebherz D, Papay P, Liepert J, Hlavin G, Lichtenberger C, et al. Anti-Gal titers in healthy adults and inflammatory bowel disease patients. Transplant Proc. 2011;43(10):3964\u20138.","journal-title":"Transplant Proc"},{"issue":"5","key":"1973_CR16","first-page":"987","volume":"63","author":"RC Unfer","year":"2003","unstructured":"Unfer RC, Hellrung D, Link Jr CJ. Immunity to the a(1,3)galactosyl epitope provides protection in mice challenged with colon cancer cells expressing a(1,3)galactosyl-transferase: a novel suicide gene for cancer gene therapy. Cancer Res. 2003;63(5):987\u201393.","journal-title":"Cancer Res"},{"issue":"5","key":"1973_CR17","first-page":"1277","volume":"23","author":"T Liu","year":"2010","unstructured":"Liu T, Cheng W, Lai D, Huang Y, Guo L. Characterization of primary ovarian cancer cells in different culture systems. Oncol Rep. 2010;23(5):1277\u201384.","journal-title":"Oncol Rep"},{"issue":"9","key":"1973_CR18","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/abbs\/gmq067","volume":"42","author":"L Ma","year":"2011","unstructured":"Ma L, Lai D, Liu T, Cheng W, Guo L. Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3. Acta Biochim Biophys Sin (Shanghai). 2011;42(9):593\u2013602.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"7","key":"1973_CR19","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00262-011-1166-4","volume":"61","author":"D Lai","year":"2012","unstructured":"Lai D, Wang F, Chen Y, Wang C, Liu S, Lu B, et al. Human ovarian cancer stem-like cells can be efficiently killed by \u03b3\u03b4 T lymphocytes. Cancer Immunol Immunother. 2012;61(7):979\u201389.","journal-title":"Cancer Immunol Immunother"},{"issue":"4","key":"1973_CR20","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1089\/dna.2005.24.235","volume":"24","author":"L Yu","year":"2005","unstructured":"Yu L, Miao H, Guo L. Effect of RNA Interference on Gal Alpha 1,3 Gal expression in PIEC Cells. DNA Cell Biol. 2005;24(4):235\u201343.","journal-title":"DNA Cell Biol"},{"issue":"11","key":"1973_CR21","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1006\/jmcc.1999.1035","volume":"31","author":"T Sakoda","year":"1999","unstructured":"Sakoda T, Kasahara N, Hamamori Y, Kedes LA. High-titer lentiviral production system mediates efficient transduction of differentiated cells including beating cardiac myocytes. J Mol Cell Cardiol. 1999;31(11):2037\u201347.","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"1973_CR22","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1172\/JCI7358","volume":"105","author":"M Tanemura","year":"2000","unstructured":"Tanemura M, Yin D, Chong AS, Galili U. Differential immune responses to alpha-gal epitopes on xenografts and allografts: implications for accommodation in xenotransplantation. J Clin Invest. 2000;105(3):301\u201310.","journal-title":"J Clin Invest"},{"issue":"1","key":"1973_CR23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1258\/la.2007.006057","volume":"42","author":"DB S\u00f8rensen","year":"2008","unstructured":"S\u00f8rensen DB, Dahl K, Ersb\u00f8ll AK, Kirkeby S, d\u2019Apice AJ, Hansen AK. Aggression in cataract-bearing a-1,3-galactosyltransferase knockout mice. Lab Anim. 2008;42(1):34\u201344.","journal-title":"Lab Anim"},{"issue":"6","key":"1973_CR24","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/sj.cgt.7700812","volume":"12","author":"L Deriy","year":"2005","unstructured":"Deriy L, Ogawa H, Gao GP, Galili U. In vivo targeting of vaccinating tumor cells to antigen presenting cells by a gene therapy method with adenovirus containing the alpha1,3-galactosyltransferase gene. Cancer Gene Ther. 2005;12(6):528\u201339.","journal-title":"Cancer Gene Ther"},{"issue":"1","key":"1973_CR25","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ygyno.2004.09.025","volume":"96","author":"CH Lee","year":"2005","unstructured":"Lee CH, Xue H, Sutcliffe M, Gout PW, Huntsman DG, Miller DM, et al. Establishment of subrenal capsule xenografts of primary human ovarian tumors in SCID mice: potential models. Gynecol Oncol. 2005;96(1):48\u201355.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"1973_CR26","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/bjc.1985.46","volume":"51","author":"S Aamdal","year":"1985","unstructured":"Aamdal S, Fodstad O, Nesland JM, Pihl A. Characteristics of human tumour xenografts transplanted under the renal capsule of immunocompetent mice. Br J Cancer. 1985;51(3):347\u201356.","journal-title":"Br J Cancer"},{"issue":"1","key":"1973_CR27","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/cncr.11476","volume":"98","author":"EV H\u00f8gdall","year":"2003","unstructured":"H\u00f8gdall EV, Christensen L, Kjaer SK, Blaakaer J, Bock JE, Glud E, et al. Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma: from the Danish MALOVA Ovarian Cancer Study. Cancer. 2003;98(1):66\u201373.","journal-title":"Cancer"},{"issue":"8","key":"1973_CR28","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1002\/1097-0142(19950415)75:8<2147::AID-CNCR2820750818>3.0.CO;2-8","volume":"75","author":"E Felip","year":"1995","unstructured":"Felip E, Del Campo JM, Rubio D, Vidal MT, Colomer R, Bermejo B. Overexpression of c-erbB-2 in epithelial ovarian cancer. Prognostic value and relationship with response to chemotherapy. Cancer. 1995;75(8):2147\u201352.","journal-title":"Cancer"},{"issue":"4","key":"1973_CR29","first-page":"429","volume":"44","author":"S Tomi\u0107","year":"2003","unstructured":"Tomi\u0107 S, Ili\u0107 Forko J, Babi\u0107 D, Sundov D, Kuret S, Andelinovi\u0107 S. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma. Croat Med J. 2003;44(4):429\u201334.","journal-title":"Croat Med J"},{"issue":"8","key":"1973_CR30","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00262-004-0653-2","volume":"54","author":"KL Knutson","year":"2005","unstructured":"Knutson KL, Disis ML. Tumor antigen-specific T helper cells in cancer immunity and immunotherapy. Cancer Immunol Immunother. 2005;54(8):721\u20138.","journal-title":"Cancer Immunol Immunother"},{"issue":"7","key":"1973_CR31","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s002620050584","volume":"48","author":"G Pawelec","year":"1999","unstructured":"Pawelec G. Tumor escape from the immune response: the last hurdle for successful immunotherapy of cancer? Cancer Immunol Immunother. 1999;48(7):343\u20135.","journal-title":"Cancer Immunol Immunother"},{"issue":"12","key":"1973_CR32","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.1073\/pnas.92.12.5540","volume":"92","author":"G Maass","year":"1995","unstructured":"Maass G, Schmidt W, Berger M, Schilcher F, Koszik F, Schneeberger A, et al. Priming of tumorspecific T cells in the draining lymph nodes after immunization with interleukin 2-secreting tumor cells: three consecutive stages may be required for successful tumor vaccination. Proc Natl Acad Sci U S A. 1995;92(12):5540\u20134.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1973_CR33","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1600-065X.1997.tb00969.x","volume":"156","author":"RM Zinkernagel","year":"1997","unstructured":"Zinkernagel RM, Ehl S, Aichele P, Oehen S, K\u00fcndig T, Hengartner H. Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity. Immunol Rev. 1997;156:199\u2013209.","journal-title":"Immunol Rev"},{"issue":"11","key":"1973_CR34","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00262-004-0524-x","volume":"53","author":"U Galili","year":"2004","unstructured":"Galili U. Autologous tumor vaccines processed to express \u03b1-gal epitopes: a practical approach to immunotherapy in cancer. Cancer Immunol Immunother. 2004;53(11):935\u201345.","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"1973_CR35","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0090-8258(03)00148-3","volume":"90","author":"U Galili","year":"2003","unstructured":"Galili U, Chen ZC, DeGeest K. Expression of alpha-gal epitopes on ovarian carcinoma membranes to be used as a novel autologous tumor vaccine. Gynecol Oncol. 2003;90(1):100\u20138.","journal-title":"Gynecol Oncol"},{"issue":"6859","key":"1973_CR36","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/35102167","volume":"414","author":"T Reya","year":"2001","unstructured":"Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001;414(6859):105\u201311.","journal-title":"Nature"},{"issue":"6","key":"1973_CR37","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1440-1711.2005.01366.x","volume":"83","author":"U Galili","year":"2005","unstructured":"Galili U. The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy. Immunol Cell Biol. 2005;83(6):674\u201386.","journal-title":"Immunol Cell Biol"},{"issue":"2","key":"1973_CR38","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bbagen.2007.11.003","volume":"1780","author":"BA Macher","year":"2008","unstructured":"Macher BA, Galili U. The Galalpha1,3Galbeta1,4GlcNAc-R (alpha-Gal) epitope: a carbohydrate of unique evolution and clinical relevance. Biochim Biophys Acta. 2008;1780(2):75\u201388.","journal-title":"Biochim Biophys Acta"},{"issue":"4A","key":"1973_CR39","first-page":"2301","volume":"18","author":"CJ Link Jr","year":"1998","unstructured":"Link Jr CJ, Seregina T, Atchison R, Hall A, Muldoon R, Levy JP. Eliciting hyperacute xenograft response to treat human cancer: \u03b1(1,3) galactosyltransferase gene therapy. Anticancer Res. 1998;18(4A):2301\u20138.","journal-title":"Anticancer Res"},{"issue":"2","key":"1973_CR40","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/sj.cr.7290076","volume":"11","author":"L Xing","year":"2001","unstructured":"Xing L, Xia GH, Fei J, Huang F, Guo LH. Adenovirus-mediated expression of pig \u03b1(1,3) galactosyltransferase reconstructs Gal \u03b1(1,3) Gal epitope on the surface of human tumor cells. Cell Res. 2001;11(2):116\u201324.","journal-title":"Cell Res"},{"issue":"4\u20135","key":"1973_CR41","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0161-5890(99)00050-4","volume":"36","author":"TE Mollnes","year":"1999","unstructured":"Mollnes TE, Fiane AE. Xenotransplantation: how to overcome the complement obstacle? Mol Immunol. 1999;36(4\u20135):269\u201376.","journal-title":"Mol Immunol"},{"key":"1973_CR42","doi-asserted-by":"crossref","first-page":"6497","DOI":"10.1073\/pnas.82.19.6497","volume":"82","author":"K Semba","year":"1985","unstructured":"Semba K, Kamata N, Toyoshima K, Yamamoto T. A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1\/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma. Proc Natl Acad Sci U S A. 1985;82:6497\u2013501.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"34","key":"1973_CR43","doi-asserted-by":"crossref","first-page":"12463","DOI":"10.1073\/pnas.0805009105","volume":"105","author":"B Xiang","year":"2008","unstructured":"Xiang B, Chatti K, Qiu H, Lakshmi B, Krasnitz A, Hicks J, et al. Brk is coamplified with ErbB2 to promote proliferation in breast cancer. Proc Natl Acad Sci U S A. 2008;105(34):12463\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7008","key":"1973_CR44","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/431525b","volume":"431","author":"P Stephens","year":"2004","unstructured":"Stephens P, Hunter C, Bignell G, Edkins S, Davies H, Teague J, et al. Lung cancer: intragenic ERBB2 kinase mutations in tumours. Nature. 2004;431(7008):525\u20136.","journal-title":"Nature"},{"issue":"3","key":"1973_CR45","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/sj.onc.1207166","volume":"23","author":"W Xia","year":"2004","unstructured":"Xia W, Liu LH, Ho P, Spector NL. Truncated ErbB2 receptor (p95ErbB2) is regulated by heregulin through heterodimer formation with ErbB3 yet remains sensitive to the dual EGFR\/ErbB2 kinase inhibitor GW572016. Oncogene. 2004;23(3):646\u201353.","journal-title":"Oncogene"},{"issue":"17","key":"1973_CR46","doi-asserted-by":"crossref","first-page":"9131","DOI":"10.1128\/JVI.00647-07","volume":"81","author":"UM Abdel-Motal","year":"2007","unstructured":"Abdel-Motal UM, Guay HM, Wigglesworth K, Welsh RM, Galili U. Increased immunogenicity of influenza virus vaccine by anti-Gal mediated targeting to antigen presenting cells. J Virol. 2007;81(17):9131\u201341.","journal-title":"J Virol"},{"issue":"12","key":"1973_CR47","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1038\/cdd.2014.96","volume":"21","author":"P Duewell","year":"2014","unstructured":"Duewell P, Steger A, Lohr H, Bourhis H, Hoelz H, Kirchleitner SV, et al. RIG-I-like helicases induce immunogenic cell death of pancreatic cancer cells and sensitize tumors toward killing by CD8(+) T cells. Cell Death Differ. 2014;21(12):1825\u201337.","journal-title":"Cell Death Differ"},{"issue":"2","key":"1973_CR48","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1074-7613(00)00026-1","volume":"13","author":"HL Hanson","year":"2000","unstructured":"Hanson HL, Donermeyer DL, Ikeda H, White JM, Shankaran V, Old LJ, et al. Eradication of established tumors by CD8+ T cell adoptive immunotherapy. Immunity. 2000;13(2):265\u201376.","journal-title":"Immunity"},{"issue":"25","key":"1973_CR49","doi-asserted-by":"crossref","first-page":"11671","DOI":"10.1073\/pnas.92.25.11671","volume":"92","author":"TC Wu","year":"1995","unstructured":"Wu TC, Guarnieri FG, Staveley-O\u2019Carroll KF, Viscidi RP, Levitsky HI, Hedrick L, et al. Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens. Proc Natl Acad Sci U S A. 1995;92(25):11671\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1973_CR50","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.immuni.2005.02.003","volume":"22","author":"A Corthay","year":"2005","unstructured":"Corthay A, Skovseth DK, Lundin KU, R\u00f8sj\u00f8 E, Omholt H, Hofgaard PO, et al. Primary antitumor immune response mediated by CD4+ T cells. Immunity. 2005;22(3):371\u201383.","journal-title":"Immunity"},{"issue":"5","key":"1973_CR51","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.3892\/ijo.2014.2308","volume":"44","author":"JE Kim","year":"2014","unstructured":"Kim JE, Jang MJ, Jin DH, Chung YH, Choi BS, Park GB, et al. Paclitaxel-exposed ovarian cancer cells induce cancer-specific CD4+ T cells after doxorubicin exposure through regulation of MyD88 expression. Int J Oncol. 2014;44(5):1716\u201326.","journal-title":"Int J Oncol"},{"issue":"4","key":"1973_CR52","first-page":"281","volume":"47","author":"AE Bogden","year":"1979","unstructured":"Bogden AE, Haskell PM, LePage DJ, Kelton DE, Cobb WR, Esber HJ. Growth of human tumor xenografts implanted under the renal capsule of normal immunocompetent mice. Exp Cell Biol. 1979;47(4):281\u201393.","journal-title":"Exp Cell Biol"},{"key":"1973_CR53","first-page":"3861","volume":"32","author":"GF Whalen","year":"2012","unstructured":"Whalen GF, Sullivan M, Piperdi B, Wasseff W, Galili U. Cancer immunotherapy by intratumoral injection of a-gal glycolipids. Anticancer Res. 2012;32:3861\u20138.","journal-title":"Anticancer Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1973-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T20:19:53Z","timestamp":1599941993000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1471-2407\/15\/956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1973"],"URL":"https:\/\/doi.org\/10.1186\/s12885-015-1973-7","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"article-number":"956"}}